
Jinghua Pharmaceutical Group Co., Ltd.
SZSE:002349.SZ
8.74 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,402.088 | 1,511.751 | 1,573.06 | 1,357.868 | 1,281.353 | 1,157.389 | 1,354.706 | 1,120.92 | 881.487 | 780.334 | 577.754 | 732.618 | 665.382 | 375.502 | 274.32 | 259.387 | 234.869 | 229.554 | 209.836 |
Cost of Revenue
| 705.569 | 775.642 | 837.915 | 725.685 | 662.32 | 631.158 | 703.911 | 561.858 | 443.814 | 479.698 | 354.482 | 521.655 | 470.9 | 230.321 | 133.394 | 133.372 | 128.612 | 129.563 | 127.48 |
Gross Profit
| 696.519 | 736.11 | 735.145 | 632.183 | 619.033 | 526.232 | 650.795 | 559.062 | 437.673 | 300.636 | 223.271 | 210.963 | 194.482 | 145.181 | 140.926 | 126.014 | 106.257 | 99.991 | 82.356 |
Gross Profit Ratio
| 0.497 | 0.487 | 0.467 | 0.466 | 0.483 | 0.455 | 0.48 | 0.499 | 0.497 | 0.385 | 0.386 | 0.288 | 0.292 | 0.387 | 0.514 | 0.486 | 0.452 | 0.436 | 0.392 |
Reseach & Development Expenses
| 61.789 | 64.62 | 86.98 | 74.758 | 52.053 | 82.755 | 40.319 | 37.667 | 42.941 | 26.639 | 15.713 | 11.868 | 10.56 | 11.127 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 118.93 | 118.805 | 148.897 | 137.616 | 125.266 | 118.912 | 115.893 | 93.909 | 128.175 | 95.013 | 75.995 | 69.124 | 67.794 | 8.146 | 37.145 | 32.733 | 30.503 | 30.587 | 29.466 |
Selling & Marketing Expenses
| 142.987 | 129.581 | 158.572 | 134.297 | 108.817 | 92.196 | 96.065 | 87.131 | 96.572 | 86.122 | 72.102 | 60.729 | 56.794 | 51.297 | 50.91 | 49.781 | 36.975 | 30.057 | 27.06 |
SG&A
| 354.69 | 349.496 | 370.255 | 331.646 | 152.31 | 415.071 | 270.89 | 243.29 | 178.463 | 168.57 | 143.364 | 137.113 | 123.017 | 89.441 | 88.055 | 82.514 | 67.478 | 60.644 | 56.526 |
Other Expenses
| 0 | -14.394 | 120.266 | 112.987 | 170.152 | 394.223 | 16.535 | 103.697 | 8.497 | 3.956 | 11.295 | 12.817 | 28.315 | 18.705 | 1.353 | 3.973 | 7.177 | 6.139 | 7.847 |
Operating Expenses
| 401.461 | 405.255 | 499.682 | 440.556 | 354.389 | 601.324 | 332.1 | 388.165 | 240.092 | 204.097 | 175.598 | 164.954 | 141.802 | 104.929 | 90.931 | 85.629 | 74.655 | 66.925 | 64.374 |
Operating Income
| 295.058 | 330.854 | 251.484 | 180.505 | 63.28 | -498.159 | 293.472 | 170.897 | 193.689 | 92.989 | 39.842 | 39.247 | 43.893 | 38.49 | 48.927 | 39.527 | 31.602 | 33.066 | 17.982 |
Operating Income Ratio
| 0.21 | 0.219 | 0.16 | 0.133 | 0.049 | -0.43 | 0.217 | 0.152 | 0.22 | 0.119 | 0.069 | 0.054 | 0.066 | 0.103 | 0.178 | 0.152 | 0.135 | 0.144 | 0.086 |
Total Other Income Expenses Net
| -1.74 | -1.159 | -1.271 | -1.618 | 0.465 | -2.501 | -5.005 | 45.924 | 8.297 | 3.735 | 11.248 | 3.577 | 28.204 | 18.687 | 1.257 | -0.451 | 0.265 | 5.794 | -0.709 |
Income Before Tax
| 293.318 | 329.695 | 250.213 | 178.887 | 63.745 | -500.66 | 288.467 | 216.821 | 201.985 | 96.724 | 51.09 | 42.824 | 72.097 | 57.176 | 50.184 | 39.076 | 31.867 | 38.86 | 17.274 |
Income Before Tax Ratio
| 0.209 | 0.218 | 0.159 | 0.132 | 0.05 | -0.433 | 0.213 | 0.193 | 0.229 | 0.124 | 0.088 | 0.058 | 0.108 | 0.152 | 0.183 | 0.151 | 0.136 | 0.169 | 0.082 |
Income Tax Expense
| 45.852 | 53.229 | 37.917 | 38.928 | 35.82 | 23.689 | 28.397 | 26.495 | 28.526 | 14.882 | 10.463 | 2.151 | 12.48 | 8.825 | 7.544 | 6.276 | 5.703 | 13.266 | 5.472 |
Net Income
| 212.652 | 247.697 | 212.225 | 160.702 | 110.994 | -393.618 | 229.665 | 175.32 | 165.03 | 78.081 | 39.468 | 35.597 | 49.223 | 48.102 | 42.639 | 32.8 | 26.163 | 25.593 | 11.802 |
Net Income Ratio
| 0.152 | 0.164 | 0.135 | 0.118 | 0.087 | -0.34 | 0.17 | 0.156 | 0.187 | 0.1 | 0.068 | 0.049 | 0.074 | 0.128 | 0.155 | 0.126 | 0.111 | 0.111 | 0.056 |
EPS
| 0.26 | 0.3 | 0.26 | 0.2 | 0.14 | -0.48 | 0.28 | 0.21 | 0.2 | 0.1 | 0.066 | 0.059 | 0.082 | 0.08 | 0.073 | 0.073 | 0.058 | 0.057 | 0.027 |
EPS Diluted
| 0.26 | 0.3 | 0.26 | 0.2 | 0.14 | -0.48 | 0.28 | 0.21 | 0.2 | 0.1 | 0.066 | 0.059 | 0.082 | 0.08 | 0.073 | 0.073 | 0.058 | 0.057 | 0.027 |
EBITDA
| 371.159 | 417.611 | 370.042 | 294.939 | 167.39 | -400.796 | 373.48 | 285.619 | 260.876 | 142.185 | 95.127 | 71.087 | 91.521 | 66.536 | 59.256 | 49.889 | 44.959 | 52.923 | 38.887 |
EBITDA Ratio
| 0.265 | 0.276 | 0.235 | 0.217 | 0.131 | -0.346 | 0.276 | 0.255 | 0.296 | 0.182 | 0.165 | 0.097 | 0.138 | 0.177 | 0.216 | 0.192 | 0.191 | 0.231 | 0.185 |